Understanding inherited genetic factors that lead to blood cancers.
Selective pressures from inherited variation impacting myeloproliferative neoplasm initiation
This study is looking at how inherited genes might play a role in the development of blood cancers called myeloproliferative neoplasms, using mice to understand how these genes affect blood stem cells, which could help patients learn more about their own genetic risks and ways to prevent these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston Children's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10867306 on NIH RePORTER |
What this research studies
This research investigates how inherited genetic variations can influence the development of myeloproliferative neoplasms (MPNs), a type of blood cancer. By utilizing advanced mouse models and genome editing techniques, the study aims to uncover the mechanisms through which these inherited factors affect blood stem cells and contribute to cancer initiation. The research will also explore the role of specific genetic mutations, such as those in the CHEK2 gene, in promoting these diseases. Patients may gain insights into their genetic risks and potential preventive measures.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with a family history of myeloproliferative neoplasms or those who have been diagnosed with related blood disorders.
Not a fit: Patients without any genetic predisposition to blood cancers or those with unrelated health conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and potentially new strategies for preventing or treating myeloproliferative neoplasms.
How similar studies have performed: Previous research has shown promising results in understanding genetic factors in blood cancers, indicating that this approach has potential for success.
Where this research is happening
Boston, United States
- Boston Children's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Sankaran, Vijay Ganesh — Boston Children's Hospital
- Study coordinator: Sankaran, Vijay Ganesh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.